Literature DB >> 9894794

Predictive testing for Huntington's disease: I. Predictors of uptake in South Wales.

J Binedell1, J R Soldan, P S Harper.   

Abstract

In Wales, predictive testing for Huntington's disease (HD) has not been offered proactively to families and uptake of testing is low in comparison to other centres. Little is known of those not requesting testing, particularly those not in direct contact with the genetics service. This study examined differences between a cohort of 22 test applicants and a random group of 32 'non-requesters', drawn from the South Wales HD register. Respondents were interviewed by means of a semi-structured schedule in their own homes. The study groups differed significantly on a number of variables including: knowledge of the availability of testing; perceived attitudes of family members and significant others to testing; length of knowledge and perceived stressfulness of being at risk; and perceived ability to cope with an unfavourable result. Overall, knowledge of testing procedures was poor and at-risk individuals' understanding of genetic terminology was at odds with scientific distinctions. Discussion focuses on the organisational and psychological factors associated with lack of knowledge of the availability of testing and the interpretation of reported coping capacities.

Entities:  

Mesh:

Year:  1998        PMID: 9894794     DOI: 10.1111/j.1399-0004.1998.tb03768.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  12 in total

1.  Prenatal diagnosis requests for Huntington's disease when the father is at risk and does not want to know his genetic status: clinical, legal, and ethical viewpoints.

Authors:  Ros Tassicker; Julian Savulescu; Loane Skene; Pam Marshall; Lara Fitzgerald; Martin B Delatycki
Journal:  BMJ       Date:  2003-02-08

2.  (Mis)alignments in counseling for Huntington's Disease predictive testing: clients' responses to reflective frames.

Authors:  Srikant Sarangi; Kristina Bennert; Lucy Howell; Angus Clarke; Peter Harper; Jonathon Gray
Journal:  J Genet Couns       Date:  2005-02       Impact factor: 2.537

Review 3.  How risk is perceived, constructed and interpreted by clients in clinical genetics, and the effects on decision making: systematic review.

Authors:  Stephanie Sivell; Glyn Elwyn; Clara L Gaff; Angus J Clarke; Rachel Iredale; Chris Shaw; Joanna Dundon; Hazel Thornton; Adrian Edwards
Journal:  J Genet Couns       Date:  2007-10-30       Impact factor: 2.537

4.  Presymptomatic testing for neurogenetic diseases in Brazil: assessing who seeks and who follows through with testing.

Authors:  Caroline Santa Maria Rodrigues; Viviane Ziebell de Oliveira; Gabriela Camargo; Claudio Maria da Silva Osório; Raphael Machado de Castilhos; Maria Luiza Saraiva-Pereira; Lavínia Schuler-Faccini; Laura Bannach Jardim
Journal:  J Genet Couns       Date:  2011-06-30       Impact factor: 2.537

5.  "Awakening to" a new meaning of being at-risk for arrhythmogenic right ventricular cardiomyopathy: a grounded theory study.

Authors:  April Manuel; Fern Brunger
Journal:  J Community Genet       Date:  2015-01-27

Review 6.  Predictors of genetic testing decisions: a systematic review and critique of the literature.

Authors:  Kate Sweeny; Arezou Ghane; Angela M Legg; Ho Phi Huynh; Sara E Andrews
Journal:  J Genet Couns       Date:  2014-04-11       Impact factor: 2.537

7.  Analysis of the Reasons for Non-Uptake of Predictive Testing for Huntington's Disease in Spain: A Qualitative Study.

Authors:  Jesús Rivera-Navarro; Esther Cubo; Natividad Mariscal
Journal:  J Genet Couns       Date:  2015-04-30       Impact factor: 2.537

Review 8.  Ethical considerations in presymptomatic testing for variant CJD.

Authors:  R E Duncan; M B Delatycki; S J Collins; A Boyd; C L Masters; J Savulescu
Journal:  J Med Ethics       Date:  2005-11       Impact factor: 2.903

9.  Making the decision to participate in predictive genetic testing for arrhythmogenic right ventricular cardiomyopathy.

Authors:  April Manuel; Fern Brunger
Journal:  J Genet Couns       Date:  2014-07-01       Impact factor: 2.537

10.  Improving service evaluation in clinical genetics: identifying effects of genetic diseases on individuals and families.

Authors:  Marion McAllister; Katherine Payne; Stuart Nicholls; Rhona MacLeod; Dian Donnai; Linda M Davies
Journal:  J Genet Couns       Date:  2007-02-13       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.